The gene, identified by researchers including one from Simon Fraser University in Canada, affects accumulation of amyloid-beta, a protein believed to be one of the main causes of the damage that underpins this brain disease in humans.
The gene encodes a protein that is important for intracellular transportation.
Each brain cell relies on an internal highway system that transports molecular signals needed for the development, communication, and survival of the cell.
This system's impairment can disrupt amyloid-beta processing, causing its eventual accumulation. This contributes to the development of amyloid plaques, which are a key hallmark of Alzheimer's disease.
"Alzheimer's, like many human disorders, has a genetic component, yet many environmental and lifestyle factors contribute to the disease as well," said Silverman.
"In a sense, it is like looking for a needle in a complex genetic haystack," he added.
The gene discovery could open new avenues for the design of therapeutics and pave the way for early detection by helping healthcare professionals identify those who are predisposed to the disease, researchers said.
"Lifestyle changes, such as improved diet, exercise, and an increase in cognitive stimulation may then help to slow the progression of Alzheimer's," he said.
The study was published in the Proceedings of the National Academy of Sciences.
